Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01629017 · ClinicalTrials.gov registry record

Long Term Effects On Recipients of Hematopoietic Stem Cell Transplantation

A clinical trial of Blood and Marrow Transplant (BMT), sponsored by Stanford University.

Recruiting
Registry status
800
Enrollment target
1
Study location

NCT01629017 is a study of Blood and Marrow Transplant (BMT) that is actively recruiting participants, run by Stanford University. The registered enrollment target is 800 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01629017, a study of Blood and Marrow Transplant (BMT), is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
800 participants
Enrollment target
1
Study location

Study Summary

This project allows for the systematic collection and analysis of long-term follow-up clinical parameters in children who have received a stem cell transplant. The data collected will assist in determining appropriate intervention and treatment plans for patients enrolled on this study. In addition, future patients may benefit by having the ability to anticipate problems and develop methods of prevention or early intervention.

Study Locations (1)

California

  • Stanford University School of Medicine - Stanford

Trial Details

FieldValue
Enrollment Target 800 participants
Start Date 1995-01
Est. Completion 2099-01

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT01629017

The ClinicalTrials.gov registry entry for NCT01629017 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Blood and Marrow Transplant (BMT) appearing as the primary indexed condition, and to 0 interventions.

NCT01629017 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01629017 about?

NCT01629017 is a clinical study titled "Long Term Effects On Recipients of Hematopoietic Stem Cell Transplantation". This project allows for the systematic collection and analysis of long-term follow-up clinical parameters in children who have received a stem cell transplant. The data collected will assist in determining appropriate intervention and treatment plans for patients enrolled on this study. In addition,...

What is the current status of trial NCT01629017?

This trial is currently recruiting. The enrollment target is 800 participants. The study started on 1995-01. Estimated completion is 2099-01.

What conditions does trial NCT01629017 study?

This clinical trial studies the following conditions: Blood and Marrow Transplant (BMT).

Who is sponsoring clinical trial NCT01629017?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01629017 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.